N-linked glycosylation plays a crucial role in the secretion of HMGB1

Journal of Cell Science

Volumn 129, Issue 1, 2016, Pages 29-38

  Kim, Young Hun ^a   Kwak, Man Sup ^a   Park, Jun Bae ^b   Lee, Shin Ae ^a   Choi, Ji Eun ^c   Cho, Hyun Soo ^b   Shin, Jeon Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

DNA binding; HMGB1; N glycosylation; Post translational modification; Secretion

Indexed keywords

EXPORTIN 1; HIGH MOBILITY GROUP B1 PROTEIN; MUTANT PROTEIN; TUNICAMYCIN; CELL RECEPTOR; DNA; EXPORTIN 1 PROTEIN; KARYOPHERIN; POLYSACCHARIDE; PROTEIN BINDING;

ACETYLATION; ARTICLE; CELL NUCLEUS; CONSENSUS; GLYCOSYLATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MUTANT; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; OXIDATION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN STRUCTURE; STIMULUS RESPONSE; TANDEM MASS SPECTROMETRY; UBIQUITINATION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CHO CELL LINE; CRICETULUS; HAMSTER; HEK293 CELL LINE; HELA CELL LINE; INTRACELLULAR SPACE; METABOLISM; MOLECULAR GENETICS; MOUSE; PROTEIN TRANSPORT; SECRETION (PROCESS);

AMINO ACID SEQUENCE; ANIMALS; CELL NUCLEUS; CHO CELLS; CHROMATOGRAPHY, LIQUID; CRICETINAE; CRICETULUS; DNA; GLYCOSYLATION; HEK293 CELLS; HELA CELLS; HMGB1 PROTEIN; HUMANS; INTRACELLULAR SPACE; KARYOPHERINS; MICE; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN TRANSPORT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TANDEM MASS SPECTROMETRY;

EID: 84958963507     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.176412     Document Type: Article

References (53)

1. Bell, C. W., Jiang, W., Reich, C. F., III and Pisetsky, D. S. (2006). The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell Physiol. 291, C1318-C1325.
2. Boffa, L. C., Sterner, R., Vidali, G. and Allfrey, V. G. (1979). Post-synthetic modifications of nuclear proteins high mobility group proteins are methylated. Biochem. Biophys. Res. Commun. 89, 1322-1327.
3. Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A. and Bianchi, M. E. (2003). Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22, 5551-5560.
4. Chao, Y. B., Scovell, W. M. and Yan, S. B. (1994). High mobility group protein, HMG-1, contains insignificant glycosyl modification. Protein Sci. 3, 2452-2454.
5. Dimov, S. I., Alexandrova, E. A. and Beltchev, B. G. (1990). Differences between some properties of acetylated and nonacetylated forms of HMG1 protein. Biochem. Biophys. Res. Commun. 166, 819-826.
6. Dupont, N., Jiang, S., Pilli, M., Ornatowski, W., Bhattacharya, D. and Deretic, V. (2011). Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J. 30, 4701-4711.
7. Einck, L. and Bustin, M. (1985). The intracellular distribution and function of the high mobility group chromosomal proteins. Exp. Cell Res. 156, 295-310.
8. Elton, T. S. and Reeves, R. (1986). Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I. Anal. Biochem. 157, 53-62.
9. Emsley, P. and Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132.
10. Gardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E. and Rubartelli, A. (2002). The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3, 995-1001.
11. Gavel, Y. and von Heijne, G. (1990). Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng. 3, 433-442.
12. Hao, P., Ren, Y. and Xie, Y. (2010). An improved protocol for N-glycosylation analysis of gel-separated sialylated glycoproteins by MALDI-TOF/TOF. PLoS ONE 5, e15096.
13. Hebert, D. N., Lamriben, L., Powers, E. T. and Kelly, J. W. (2014). The intrinsic and extrinsic effects of N-linked glycans on glycoproteostasis. Nat. Chem. Biol. 10, 902-910.
14. Hoppe, G., Talcott, K. E., Bhattacharya, S. K., Crabb, J. W. and Sears, J. E. (2006). Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp. Cell Res. 312, 3526-3538.
15. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D. et al. (1995). The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752-25761.
16. Ito, I., Fukazawa, J. and Yoshida, M. (2007). Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J. Biol. Chem. 282, 16336-16344.
17. Kimura, K., Katoh, N., Sakurada, K. and Kubo, S. (1985). Phosphorylation of high mobility group 1 protein by phospholipid-sensitive Ca2+-dependent protein kinase from pig testis. Biochem. J. 227, 271-276.
18. Kwak, M. S., Lim, M., Lee, Y. J., Lee, H. S., Kim, Y. H., Youn, J. H., Choi, J. E. and Shin, J. -S. (2015). HMGB1 binds to lipoteichoic acid and enhances TNF-α and IL-6 production through HMGB1-mediated transfer of lipoteichoic acid to CD14 and TLR2. J. Innate immun. 7, 405-416.
19. Leahy, D. J., Rule, G. S., Whittaker, M. M. and McConnell, H. M. (1988). Sequences of 12 monoclonal anti-dinitrophenyl spin-label antibodies for NMR studies. Proc. Natl. Acad. Sci. USA 85, 3661-3665.
20. Li, J., Wang, H., Mason, J. M., Levine, J., Yu, M., Ulloa, L., Czura, C. J., Tracey, K. J. and Yang, H. (2004). Recombinant HMGB1 with cytokine-stimulating activity. J. Immunol. Methods 289, 211-223.
21. Lotze, M. T. and Tracey, K. J. (2005). High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331-342.
22. Lu, B., Nakamura, T., Inouye, K., Li, J., Tang, Y., Lundbäck, P., Valdes-Ferrer, S. I., Olofsson, P. S., Kalb, T., Roth, J. et al. (2012). Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488, 670-674.
23. Marshall, R. D. (1974). The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins. Biochem. Soc. Symp., 40, 17-26.
24. Min, H. J., Ko, E. A., Wu, J., Kim, E. S., Kwon, M. K., Kwak, M. S., Choi, J. E., Lee, J. E. and Shin, J. -S. (2013). Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates. J. Immunol. 190, 1797-1806.
25. Molinari, M. (2007). N-glycan structure dictates extension of protein folding or onset of disposal. Nat. Chem. Biol. 3, 313-320.
26. Nyström, S., Antoine, D. J., Lundbäck, P., Lock, J. G., Nita, A. F., Högstrand, K., Grandien, A., Erlandsson-Harris, H., Andersson, U. and Applequist, S. E. (2013). TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis. EMBO J. 32, 86-99.
27. Ombrellino, M., Wang, H., Ajemian, M. S., Talhouk, A., Scher, L. A., Friedman, S. G. and Tracey, K. J. (1999). Increased serum concentrations of high-mobilitygroup protein 1 in haemorrhagic shock. Lancet 354, 1446-1447.
28. Park, J. S., Svetkauskaite, D., He, Q., Kim, J. -Y., Strassheim, D., Ishizaka, A. and Abraham, E. (2004). Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370-7377.
29. Reeves, R. and Chang, D. (1983). Investigations of the possible functions for glycosylation in the high mobility group proteins. Evidence for a role in nuclear matrix association. J. Biol. Chem. 258, 679-687.
30. Reeves, R., Chang, D. and Chung, S. C. (1981). Carbohydrate modifications of the high mobility group proteins. Proc. Natl. Acad. Sci. USA 78, 6704-6708.
31. Salmivirta, M., Rauvala, H., Elenius, K. and Jalkanen, M. (1992). Neurite growthpromoting protein (amphoterin, p30) binds syndecan. Exp. Cell Res. 200, 444-451.
32. Scaffidi, P., Misteli, T. and Bianchi, M. E. (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195.
33. Schiraldi, M., Raucci, A., Munoz, L. M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De Marchis, F., Pedotti, M., Bachi, A. et al. (2012). HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J. Exp. Med. 209, 551-563.
34. Schwarz, F. and Aebi, M. (2011). Mechanisms and principles of N-linked protein glycosylation. Curr. Opin. Struct. Biol. 21, 576-582.
35. Sha, Y., Zmijewski, J., Xu, Z. and Abraham, E. (2008). HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 180, 2531-2537.
36. Sterner, R., Vidali, G. and Allfrey, V. G. (1979). Studies of acetylation and deacetylation in high mobility group proteins. Identification of the sites of acetylation in HMG-1. J. Biol. Chem. 254, 11577-11583.
37. Stott, K., Tang, G. S., Lee, K. -B. and Thomas, J. O. (2006). Structure of a complex of tandem HMG boxes and DNA. J. Mol. Biol. 360, 90-104.
38. Sun, I. Y., Johnson, E. M. and Allfrey, V. G. (1980). Affinity purification of newly phosphorylated protein molecules. Thiophosphorylation and recovery of histones H1, H2B, and H3 and the high mobility group protein HMG-1 using adenosine 5′-O-(3-thiotriphosphate) and cyclic AMP-dependent protein kinase. J. Biol. Chem. 255, 742-747.
39. Sundén-Cullberg, J., Norrby-Teglund, A., Rouhiainen, A., Rauvala, H., Herman, G., Tracey, K. J., Lee, M. L., Andersson, J., Tokics, L. and Treutiger, C. J. (2005). Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med. 33, 564-573.
40. Tang, D., Kang, R., Livesey, K. M., Cheh, C. -W., Farkas, A., Loughran, P., Hoppe, G., Bianchi, M. E., Tracey, K. J., Zeh, H. J. III et al. (2010). Endogenous HMGB1 regulates autophagy. J. Cell Biol. 190, 881-892.
41. Tanuma, S. -I., Yagi, T. and Johnson, G. S. (1985). Endogenous ADP ribosylation of high mobility group proteins 1 and 2 and histone H1 following DNA damage in intact cells. Arch. Biochem. Biophys. 237, 38-42.
42. Thorburn, J., Horita, H., Redzic, J., Hansen, K., Frankel, A. E. and Thorburn, A. (2009). Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ. 16, 175-183.
43. Tian, J., Avalos, A. M., Mao, S. -Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C. et al. (2007). Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487-496.
44. Valliere-Douglass, J. F., Eakin, C. M., Wallace, A., Ketchem, R. R., Wang, W., Treuheit, M. J. and Balland, A. (2010). Glutamine-linked and non-consensus asparagine-linked oligosaccharides present in human recombinant antibodies define novel protein glycosylation motifs. J. Biol. Chem. 285, 16012-16022.
45. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. et al. (1999). HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251.
46. Watson, M., Stott, K. and Thomas, J. O. (2007). Mapping intramolecular interactions between domains in HMGB1 using a tail-truncation approach. J. Mol. Biol. 374, 1286-1297.
47. Welply, J. K., Shenbagamurthi, P., Lennarz, W. J. and Naider, F. (1983). Substrate recognition by oligosaccharyltransferase. Studies on glycosylation of modified Asn-X-Thr/Ser tripeptides. J. Biol. Chem. 258, 11856-11863.
48. Yang, H., Hreggvidsdottir, H. S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lu, B., Chavan, S., Rosas-Ballina, M., Al-Abed, Y. et al. (2010). A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. USA 107, 11942-11947.
49. Yang, L., Xie, M., Yang, M., Yu, Y., Zhu, S., Hou, W., Kang, R., Lotze, M. T., Billiar, T. R., Wang, H. et al. (2014). PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat. Commun. 5, 4436.
50. Yang, H., Wang, H., Ju, Z., Ragab, A. A., Lundback, P., Long, W., Valdes-Ferrer, S. I., He, M., Pribis, J. P., Li, J. et al. (2015). MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J. Exp. Med. 212, 5-14.
51. Youn, J. H. and Shin, J. -S. (2006). Nucleocytoplasmic shuttling of HMGB1 Is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 177, 7889-7897.
52. Youn, J. H., Oh, Y. J., Kim, E. S., Choi, J. E. and Shin, J. -S. (2008). High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-α production in human monocytes. J. Immunol. 180, 5067-5074.
53. Zou, J., Kawai, T., Tsuchida, T., Kozaki, T., Tanaka, H., Shin, K. -S., Kumar, H. and Akira, S. (2013). Poly IC triggers a cathepsin D- and IPS-1-dependent pathway to enhance cytokine production and mediate dendritic cell necroptosis. Immunity 38, 717-728.